A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis
Condition: Moderate to Severe Ulcerative Colitis Interventions: Drug: 50 mg; Drug: 450 mg; Drug: 150 mg; Other: 0 mg Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials